HomeCompareCYBN vs O

CYBN vs O: Dividend Comparison 2026

CYBN yields 24.15% · O yields 5.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBN wins by $71.2K in total portfolio value
10 years
CYBN
CYBN
● Live price
24.15%
Share price
$8.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.9K
Annual income
$10,269.79
Full CYBN calculator →
O
Realty Income Corporation
● Live price
5.97%
Share price
$52.30
Annual div
$3.12
5Y div CAGR
3.2%
Payout ratio
76%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$1,416.15
Full O calculator →

Portfolio growth — CYBN vs O

📍 CYBN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBNO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBN + O cover 8 of 12 monthsgood coverage

Jan
O
Feb
O
Mar
Apr
May
Jun
Jul
O
Aug
O
Sep
O
Oct
O
Nov
O
Dec
O
CYBN pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBN
Annual income on $10K today (after 15% tax)
$2,053.14/yr
After 10yr DRIP, annual income (after tax)
$8,729.32/yr
O
Annual income on $10K today (after 15% tax)
$507.07/yr
After 10yr DRIP, annual income (after tax)
$1,203.73/yr
At 15% tax rate, CYBN beats the other by $7,525.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBN + O for your $10,000?

CYBN: 50%O: 50%
100% O50/50100% CYBN
Portfolio after 10yr
$58.3K
Annual income
$5,842.97/yr
Blended yield
10.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CYBN
Analyst Ratings
4
Buy
Consensus: Buy
Altman Z
4.3
Piotroski
0/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+22.4% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBN buys
0
O buys
0
No recent congressional trades found for CYBN or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBNO
Forward yield24.15%5.97%
Annual dividend / share$2.00$3.12
Payout ratio50%76%
1-year div growth0%2.8%
5-year div CAGR0%3.2%
Portfolio after 10y$93.9K$22.7K
Annual income after 10y$10,269.79$1,416.15
Total dividends collected$58.5K$9.6K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: CYBN vs O ($10,000, DRIP)

YearCYBN PortfolioCYBN Income/yrO PortfolioO Income/yrGap
1← crossover$13,115$2,415.46$10,826$615.65+$2.3KCYBN
2$16,994$2,960.73$11,727$673.66+$5.3KCYBN
3$21,769$3,585.38$12,710$737.59+$9.1KCYBN
4$27,585$4,292.32$13,785$808.08+$13.8KCYBN
5$34,600$5,083.28$14,961$885.87+$19.6KCYBN
6$42,980$5,958.72$16,247$971.76+$26.7KCYBN
7$52,907$6,917.79$17,655$1,066.66+$35.3KCYBN
8$64,569$7,958.38$19,197$1,171.57+$45.4KCYBN
9$78,166$9,077.18$20,888$1,287.65+$57.3KCYBN
10$93,907$10,269.79$22,743$1,416.15+$71.2KCYBN

CYBN vs O: Complete Analysis 2026

CYBNStock

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Full CYBN Calculator →

OREIT

Nicknamed 'The Monthly Dividend Company', Realty Income is a net-lease REIT with 15,000+ properties across the US and Europe. It has paid monthly dividends for 55+ consecutive years with 126 dividend increases since 1994 — a true Dividend Aristocrat. Its tenants include Walgreens, Dollar General, and FedEx. A cornerstone holding for income investors.

Full O Calculator →
📬

Get this CYBN vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBN vs SCHDCYBN vs JEPICYBN vs KOCYBN vs MAINCYBN vs STAGCYBN vs ADCCYBN vs NNNCYBN vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.